These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression. Ye P; Hu X; Liu Y; Zhao Y Chin Med J (Engl); 2003 Jan; 116(1):29-33. PubMed ID: 12667383 [TBL] [Abstract][Full Text] [Related]
11. Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells. Qin Q; Chen M; Yi B; You X; Yang P; Sun J J Mol Cell Cardiol; 2014 Dec; 77():20-8. PubMed ID: 25284689 [TBL] [Abstract][Full Text] [Related]
12. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone. Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1. Fahmi H; Pelletier JP; Di Battista JA; Cheung HS; Fernandes JC; Martel-Pelletier J Osteoarthritis Cartilage; 2002 Feb; 10(2):100-8. PubMed ID: 11869069 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. Shipley JM; Waxman DJ Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors and the control of inflammation. Cabrero A; Laguna JC; Vázquez M Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188 [TBL] [Abstract][Full Text] [Related]
18. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Shipley JM; Waxman DJ Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640 [TBL] [Abstract][Full Text] [Related]
20. Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads. Fu M; Zhang J; Lin Y; Zhu X; Zhao L; Ahmad M; Ehrengruber MU; Chen YE Biochem J; 2003 Mar; 370(Pt 3):1019-25. PubMed ID: 12457461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]